People in Flanders under 41 years old will soon be able to still get the Johnson & Johnson vaccine on a voluntary basis, announced Flemish Welfare Minister Wouter Beke after the interministerial health conference.
“QVAX is currently being adjusted so that [under-41s] can indicate that they want the vaccine,” Beke tweeted. “The number of people who will get J&J will depend on the deliveries.”
Mensen <41 jaar kunnen zich binnenkort vrijwillig kandidaat stellen om het J&J vaccin te krijgen. QVAX wordt op dit moment aangepast, zodat ze kunnen aanduiden dat ze het vaccin willen. Hoeveel personen J&J krijgen, hangt af van de leveringen. #IMC@ZorgVlaanderen
The FDA is investigating a number of batches of the vaccine after problems were discovered during an inspection of a factory at a subcontractor of Johnson & Johnson in the US city of Baltimore a few weeks ago.
“In the best-case scenario, Europe can expect 35 million Johnson & Johnson vaccines in the coming weeks, 900,000 of which for Belgium,” Dirk Ramaekers, the head of the Vaccination Task Force, said during a press briefing on Saturday.
“In the worst-case scenario, Europe will only receive 18 million doses, of which 450,000 for Belgium,” he added. “Obviously, that would mean a delay for our vaccination campaign.”
Following the decision to implement an age limit for the vaccine and the news about the blocked deliveries at the end of May, Beke already announced delays as it would no longer be feasible to give every adult their first shot before the initial aim of 11 July.